CN119563016A - 克劳氏芽孢杆菌菌株、其组合物及使用方法 - Google Patents

克劳氏芽孢杆菌菌株、其组合物及使用方法 Download PDF

Info

Publication number
CN119563016A
CN119563016A CN202280089645.XA CN202280089645A CN119563016A CN 119563016 A CN119563016 A CN 119563016A CN 202280089645 A CN202280089645 A CN 202280089645A CN 119563016 A CN119563016 A CN 119563016A
Authority
CN
China
Prior art keywords
bacillus
bacillus clausii
csi08
strain
clausii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280089645.XA
Other languages
English (en)
Chinese (zh)
Inventor
约翰·迪顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dylan Probiotics And Enzymes
Original Assignee
Dylan Probiotics And Enzymes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dylan Probiotics And Enzymes filed Critical Dylan Probiotics And Enzymes
Publication of CN119563016A publication Critical patent/CN119563016A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
CN202280089645.XA 2021-12-08 2022-12-08 克劳氏芽孢杆菌菌株、其组合物及使用方法 Pending CN119563016A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20210209 2021-12-08
IE2021/0209 2021-12-08
PCT/US2022/081161 WO2023108055A1 (en) 2021-12-08 2022-12-08 Bacillus clausii strain, compositions thereof, and methods of use

Publications (1)

Publication Number Publication Date
CN119563016A true CN119563016A (zh) 2025-03-04

Family

ID=85076311

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280089645.XA Pending CN119563016A (zh) 2021-12-08 2022-12-08 克劳氏芽孢杆菌菌株、其组合物及使用方法

Country Status (10)

Country Link
US (1) US20250170188A1 (https=)
EP (1) EP4444861A1 (https=)
JP (1) JP2024545064A (https=)
KR (1) KR20240141161A (https=)
CN (1) CN119563016A (https=)
AU (1) AU2022407518A1 (https=)
CA (1) CA3239840A1 (https=)
MX (1) MX2024006846A (https=)
WO (1) WO2023108055A1 (https=)
ZA (1) ZA202404358B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118511996A (zh) * 2024-04-25 2024-08-20 晏龙国科(山东)微生物科技有限公司 一种含益生菌的抗衰老组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160838B2 (en) * 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions

Also Published As

Publication number Publication date
MX2024006846A (es) 2024-08-19
ZA202404358B (en) 2025-09-25
EP4444861A1 (en) 2024-10-16
JP2024545064A (ja) 2024-12-05
KR20240141161A (ko) 2024-09-25
AU2022407518A1 (en) 2024-06-20
CA3239840A1 (en) 2023-06-15
WO2023108055A1 (en) 2023-06-15
US20250170188A1 (en) 2025-05-29

Similar Documents

Publication Publication Date Title
JP7801294B2 (ja) クロストリジウム・ディフィシル感染症の治療における新たな使用
Yan et al. A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation
RU2664479C2 (ru) Композиции и способы
JP4455333B2 (ja) プロバイオティック細菌：Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍ
US8557233B2 (en) Probiotic bifidobacterium strains
KR101470352B1 (ko) 위장관 및 면역-관련 질환의 예방 및 치료를 위한 바실루스ｐｂ6의 용도
EP2179028B1 (en) A novel strain of bifidobacterium and active peptides against rotavirus infections
JP6587614B2 (ja) プロバイオティクスとしてのラクトバチルス属の菌株
US20250170189A1 (en) Bacillus megaterium strain, compositions thereof, and methods of use
CN112218646A (zh) 一种组合物及其应用
US20220323390A1 (en) Dietary supplement to promote gut health
US20250170188A1 (en) Bacillus clausii strain, compositions thereof, and methods of use
CN112236154A (zh) 一种组合物及其应用
US20250161374A1 (en) Bacillus coagulans strain, compositions thereof, and methods of use
Nader-Macias et al. Advances in the knowledge and clinical applications of lactic acid bacteria as probiotics in the urogenital tract
CN112236155B (zh) 一种组合物及其应用
WO2025232864A1 (zh) 一种另枝杆菌及其在肠炎治疗中的用途
HK40104391A (en) Treatment of clostridium difficile infection
Chegdani Effects of Streptococcus thermophilus bacteria on rat gene expression profiles
Unger et al. Probiotics and Health Claims Related to OTC Products and Pharmaceutical Preparations
HK40042147A (en) Composition and uses thereof
HK40007703A (en) Treatment of clostridium difficile infection
HK40007703B (en) Treatment of clostridium difficile infection

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination